The Company continues to anticipate that the totality of its early-stage research programs will comprise less than 20% of overall expenditure.

Analyst Jeffrey Hung from Morgan Stanley maintained a Buy rating on Insmed (INSM – Research Report) and keeping the price target at $85.00.Stay ...

Bank of America Securities analyst Jason Zemansky reiterated a Buy rating on Insmed (INSM – Research Report) yesterday and set a price target ...

Shares of Insmed Incorporated (NASDAQ:INSM – Get Free Report) have received a consensus recommendation of “Buy” from the sixteen research firms that are currently covering the firm, MarketBeat.com ...

The powerful Inspiration Elite is the newest and lightest compressor nebulizer system in the Respironics family is here. It's durable, easy to use and easy to maintain. But best of all ...

A case study by Wu et al. [23] reported lidocaine toxicity in a 48-kg woman with multiple health conditions receiving nebulized lidocaine before bronchoscopy. She received an approximate total ...

One class of drugs that is frequently used in a nebulized form is the opioids. The mechanism of action of nebulized opioids is uncertain, but it is thought that the opioids either act on receptors ...